2004

The Health-Care Catastrophe That Won’t Happen Why biotech gains will rein in medical costs. The lesson of info tech

Will U.S. try to circumvent drug firms patent? : The furor over Abbott Laboratories’ 400 percent price increase last December

Another gene genie out of the bottle The European Commission has lifted a five-year moratorium on genetically modified produce, by

Could patients glean stock tips?: Drug trial participants may be insider trading. “Patients in clinical trials might be using information

Financial Snapshot For March 2004: Looking Good “It’s been a rocky first quarter for the biotech stocks � and for

Full Steam Ahead “All told, biotech and specialty pharmas raised close to $6.4 billion in the first three months of

Money-Back Guarantee On Rx Drugs “Too many people with high blood pressure quit medication because they don’t feel bad –

Can the world afford to reject GM foods? “At a meeting in Brussels this week Dr Clive James, chair of

Are biotech jobs next to go? There are signs that the nation’s biotech industry may be on the verge of

Financial Snapshot For March 2004: Looking Good 04/14/2004